GB

United Kingdom

28690 clinical trials

Find Trials

Clinical Trials (28690)

Showing 20 of 28,690 trialsScroll for more
NCT06118255Phase 32 sites

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

Active Not Recruiting
NCT07286578Not Applicable5 sites

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

Recruiting
NCT05307705Phase 12 sites

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Recruiting
NCT04728893Phase 28 sites

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Recruiting
NCT07107945Phase 38 sites

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

Recruiting
NCT07613294Phase 310 sites

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Recruiting

Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell Disorder

Completed
NCT07157254Phase 22 sites

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

Recruiting
NCT03105102Phase 316 sites

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

Active Not Recruiting
NCT04099251Phase 32 sites

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

Active Not Recruiting
NCT06422143Phase 34 sites

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Recruiting
NCT03955445Phase 33 sites

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

Recruiting
NCT05999994Phase 25 sites

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Recruiting
NCT06722235Phase 310 sites

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Recruiting
NCT06980480Phase 35 sites

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Recruiting
NCT06841354Phase 38 sites

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Recruiting
NCT06215716Phase 39 sites

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Recruiting
NCT06951217Phase 25 sites

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Recruiting

Individual Variability of Experimental Gingivitis Response

Completed
NCT05139017Phase 23 sites

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Recruiting